Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Ulcerative Colitis

NCT02065557 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

101

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis

Interventions

BIOLOGICAL: Adalimumab
BIOLOGICAL: Placebo

Sponsor

AbbVie